Tg Therapeutics (TGTX) Inventory Average (2023 - 2026)
Tg Therapeutics (TGTX) posted quarterly Inventory Average of $127.3 million for Q1 2026, down 5.07% year-over-year from $134.1 million in Q1 2025, and down 6.58% quarter-over-quarter from $136.3 million in Q4 2025.
Tg Therapeutics (TGTX) Inventory Average (2023 - 2026) Analysis & Trends
Tg Therapeutics' Inventory Average history runs 4 years deep, the most recent figure standing at $127.3 million for Q1 2026.
- In Q1 2026, Inventory Average fell 5.07% year-over-year to $127.3 million; the TTM figure through Mar 2026 stood at $127.3 million (down 5.07% YoY), while the FY2025 annual figure was $118.0 million, up 57.07% from the prior year.
- Inventory Average for Q1 2026 stood at $127.3 million, down from $136.3 million in the prior quarter.
- The five-year high for Inventory Average was $156.5 million in Q2 2025, with the low at $28.7 million in Q2 2023.
- The 4-year median for Inventory Average is $90.3 million (2024), against an average of $93.4 million.
- The sharpest annual moves came in 2024 and 2026: Inventory Average jumped 176.67% in 2024, then declined 5.07% in 2026.
- Tg Therapeutics' Inventory Average stood at $36.7 million in 2023, then surged by 165.93% to $97.6 million in 2024, then soared by 39.67% to $136.3 million in 2025, then fell by 6.58% to $127.3 million in 2026.
- Business Quant data shows TGTX's Inventory Average at $127.3 million in Q1 2026, $136.3 million in Q4 2025, and $151.1 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 1.77 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 3.09 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 707.10 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 355,998.06 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 90.57 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 137.65 Mn |
| 10 | Tg Therapeutics | 7.46 Bn | 6.78 Bn | 199.14 Mn | 138.50 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 138.50 Mn |
| Mar 31, 2026 | 127.31 Mn |
| Dec 31, 2025 | 136.27 Mn |
| Sep 30, 2025 | 151.08 Mn |
| Jun 30, 2025 | 156.48 Mn |
| Mar 31, 2025 | 134.11 Mn |
| Dec 31, 2024 | 97.56 Mn |
| Sep 30, 2024 | 82.96 Mn |
| Jun 30, 2024 | 79.48 Mn |
| Mar 31, 2024 | 58.77 Mn |
| Dec 31, 2023 | 36.69 Mn |
| Sep 30, 2023 | 31.89 Mn |
| Jun 30, 2023 | 28.73 Mn |